Abstract: A sliding interlocking reclining device for a vehicle seat is configured to implement a reclining operation linked to a sliding operation of the vehicle seat. The sliding interlocking reclining device has a simpler structure than that of the related art, thereby reducing cost and weight and preventing occurrence of joint noise between parts during driving of a vehicle.

Abstract: The present invention relates to a composition for preparing retinoid, and more specifically, the composition comprises: a NADH or NADPH, a Beta-Carotene Oxygenase and a flavodoxin or a ferredoxin or a reductase of flavodoxin or ferredoxin; or a microorganism expressing them; or a culture or pulverized product of the microorganism, and thus can expand the supply metabolism of reducing electrons to enhance retinoid productivity through an increase in the activity of the cytochrome P450 system and provide a foundation for the low-cost production of raw materials, and thereby enhance the economic feasibility and efficiency of retinoid production.

Abstract: A seatback locking device may include a locking housing coupled to a seatback, the locking housing having one open side defined as a housing internal space, a rotation cap inserted into the housing internal space and rotatably coupled to the locking housing, a stopper configured to be movable along a guide defined in the locking housing so as to be locked to or unlocked from a hook bracket disposed on a vehicle body, and a cable connected to one end of the stopper so as to rotate the stopper, wherein the stopper is rotated about an axis between both ends of the stopper by movement of the cable or rotation of the rotation cap so as to contact the hook bracket or the rotation cap.

Abstract: The present invention relates to: a substituted thiazolidinedione derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a hydrate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating cancer, comprising same as an active ingredient.

Abstract: Provided is a method of manufacturing an ethylene-acrylic acid copolymer including the step of (S1) supplying an ethylene monomer and an acrylic acid comonomer to a polymerization reactor to manufacture an ethylene-acrylic acid copolymer; (S2) supplying an acrylic acid comonomer-containing mixture discharged from a front or rear end of the polymerization reactor and a cleaning solvent to a cleaning unit; and (S3) dissolving an polyacrylic acid derived from the acrylic acid comonomer contained in the mixture in the cleaning solvent. The cleaning solvent includes a polyhydric alcohol-based solvent.

Abstract: A secondary battery comprising a positive electrode current collector, a first positive electrode mixture layer disposed on the positive electrode current collector and including a first positive electrode active material and a binder, and a second positive electrode mixture layer disposed on the first positive electrode mixture layer and including a second positive electrode active material and a binder. A nickel content of the second positive electrode active material is 80% by weight or less of a nickel content of the first positive electrode active material. By providing a secondary battery including a positive electrode of a multi-layer structure that includes positive electrode active materials having different contents of nickel, a secondary battery capable of improving high-temperature characteristics while maintaining energy density may be provided.

Abstract: Provided is a composition and a fructose production method, wherein the composition contains: sucrose phosphorylase or a microorganism expressing same; or a culture or lysate of the microorganism whereby fructose can be produced at low cost with high yield.

Abstract: The present invention provides a marker composition for selecting a living modified organism, which allows transformation and the production of a target product without antibiotics or antibiotic resistance genes, a living modified organism, a method of transforming an organism, and a method of producing a target product. The present invention provides a marker composition for selecting a living modified organism, which may basically prevent problems caused by the use of antibiotics and antibiotic resistance genes and produce a target product at a high yield, a living modified organism, a method of transforming an organism, and a method of producing a target product.

Abstract: A marker composition for selecting a living modified organism allows transformation and the production of a target product without antibiotics or antibiotic resistance genes. The marker composition for selecting a living modified organism may basically prevent problems caused by the use of antibiotics and antibiotic resistance genes and produce a target product at a high yield.

Abstract: A marker composition for selecting a living modified organism allows transformation and the production of a target product without antibiotics or antibiotic resistance genes. The marker composition for selecting a living modified organism may basically prevent problems caused by the use of antibiotics and antibiotic resistance genes and produce a target product at a high yield.